Li, Shiyi
Zhang, Ru
Wang, Anni
Li, Yang
Zhang, Miaomiao
Kim, Jisu
Zhu, Ying
Wang, Qizheng
Zhang, Yue
Wei, Ying
Wang, Jianxin
Funding for this research was provided by:
National Natural Science Foundation of China (81773911)
the Development Project of Shanghai Peak Disciplines Integrated Medicine (20180101)
Article History
Received: 9 August 2023
Accepted: 13 October 2023
First Online: 10 November 2023
Declarations
:
: Protocols of animal experiments included in this study were approved by the Ethics Committee of School of Pharmacy, Fudan University (2020–12-YJ-WJX-01). Informed consent was obtained from all individual participants included in the study.
: I, the undersigned, give my consent for the publication of identifiable details, which can include photograph(s) and/or details within the text to be published in the above Journal and Article.
: We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, “<i>Panax notoginseng—derived Exosome-like Nanoparticles Attenuate Ischemia Reperfusion Injury </i>via<i> Altering Microglia Polarization</i>”.